Molecular Medicine Israel

Clinical Proteomic Tumor Analysis Consortium (CPTAC)

Resource-based frameworks to better understand and treat human cancers through the application of proteogenomics

Cell Press is proud to present papers from the Clinical Proteomic Tumor Analysis Consortium (CPTAC). This consortium is the National Cancer Institute’s initiative to accelerate our understanding of the molecular basis of cancer through the application of large-scale proteome and genome analysis, collectively known as proteogenomics, that is then further supported with additional multiomics analyses. Also included below are papers that are a collaboration between CPTAC and the International Cancer Proteogenome Consortium (ICPC). Collectively these papers provide strong resource-based frameworks to better understand a range of human cancers through the lens of precision oncology and will be valuable in informing effective treatment options.

Sign up for our Newsletter